For Immediate Release:
|Contact:||Allen & Caron Inc||CLOSURE Medical Corp|
|Joe Allen (investors)||Len Hall (media)||Benny Ward, CFO|
|(212) 691-8087||(949) 474-4300||(919) 876-7800|
RALEIGH, NC (February 3, 2005) … CLOSURE Medical Corporation (Nasdaq:CLSR), a global leader in biomaterial-based medical devices, is scheduled to present at the Merrill Lynch 2005 Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York City on Thursday, February 10, 2005.
Daniel A. Pelak, President and CEO, will deliver the Company’s presentation beginning at approximately 1:15 PM EST. Interested parties may access the live audio webcast of the presentation by visiting the Investor Relations section of the Company’s website at www.closuremed.com; an archived version of the webcast will be available for 14 days.
About CLOSURE Medical Corporation
CLOSURE Medical Corporation (Nasdaq:CLSR) is a global leader in the development and manufacture of innovative biomaterial-based medical devices that fulfill the needs of healthcare practitioners, patients and consumers.
For additional information on CLOSURE Medical visit its website at www.closuremed.com or visit the “Clients” section of the Allen & Caron website at www.allencaron.com.